Results of a multi-institutional clinical trial recently published in the Journal of Clinical Oncology show that surgically removing affected lymph nodes in the retroperitoneum of patients with early metastatic seminoma is an effective alternative to chemotherapy and radiation, with fewer long-term side effects.
When Larry Einhorn was a young physician in the early 1970s, actinomycin-D was the standard drug used to treat testicular cancer. It was—and still is—the most common carcinoma in young men ages 15-35.
